Summary of Study ST002135
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001352. The data can be accessed directly via it's Project DOI: 10.21228/M8ZD7C This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST002135 |
Study Title | Alignment and Analysis of a Disparately Acquired Multi-Batch Metabolomics Study of Maternal Pregnancy Samples. (Part 2) |
Study Summary | This is an untargeted RPLC-MS metabolomics study of mother-infant pairs from the State of Michigan. Maternal plasma was collected in the first and third trimesters of gestation, as well as umbilical cord blood, with the aim of studying metabolic changes throughout pregnancy and influences on the infant's metabolome. The data is split into two experiment subsets, assayed with different H2O-methanol gradients and mass spectrometers 2-3 years apart, inducing major chromatographic and signal measurement shifts. Analysis steps consisted of disparate LC-MS alignment and data normalization, followed by differential timepoint comparisons and partial correlation network construction. |
Institute | University of Michigan |
Department | Computational Medicine and Bioinformatics |
Last Name | Habra |
First Name | Hani |
Address | 100 Washtenaw Ave., Palmer Commons Bldg. Ann Arbor, MI 48109-2218 |
hhani@umich.edu | |
Phone | 734-615-9314 |
Submit Date | 2022-04-13 |
Raw Data Available | Yes |
Raw Data File Type(s) | d, wiff |
Analysis Type Detail | LC-MS |
Release Date | 2022-05-02 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR001352 |
Project DOI: | doi: 10.21228/M8ZD7C |
Project Title: | Influence of prenatal exposures to metals, BPA, and phthalates on mother and child metabolite and lipid profiles |
Project Summary: | The goal of the project is to examine relationships between prenatal exposures (to metals, BPA, and phthalates) and metabolite and lipid profiles using untargeted approaches in mother-infant pairs from the Michigan Mother Infant Pairs (MMIP) cohort. We are interested in differences/correlations between family samples over time, and the extent to which maternal exposures impact the lipidomes and metabolomes of both family members. Three plasma samples were analyzed from each family: two maternal samples (from first trimester and time of admission for labor and delivery) and one child sample (from cord blood). Placentas were also collected. Mothers provided detailed demographic information and clinical phenotypes were obtained, including mid-gestation fetal ultrasound. |
Institute: | University of Michigan |
Department: | Biomedical Research Core Facilities |
Laboratory: | Metabolomics core |
Last Name: | Kachman |
First Name: | Maureen |
Address: | 2900 Huron Parkway, Ann Arbor, MI, 48105, USA |
Email: | mkachman@med.umich.edu |
Phone: | 734-232-0842 |
Subject:
Subject ID: | SU002220 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | SampleType | BATCH | LIPIDOMICS_BATCH |
---|---|---|---|---|
SA205024 | - | - | - | - |
SA205027 | M3_VP_ARMII_064 | Delivery maternal plasma | 1 | 1 |
SA205028 | M3_VP_ARMII_054 | Delivery maternal plasma | 1 | 1 |
SA205029 | M3_VP_ARMII_063 | Delivery maternal plasma | 1 | 1 |
SA205030 | M3_VP_ARMII_031 | Delivery maternal plasma | 1 | 1 |
SA205031 | M3_VP_ARMII_015 | Delivery maternal plasma | 1 | 1 |
SA205032 | M3_VP_ARMII_020 | Delivery maternal plasma | 1 | 1 |
SA205033 | M3_VP_ARMII_033 | Delivery maternal plasma | 1 | 1 |
SA205034 | M3_VP_ARMII_051 | Delivery maternal plasma | 1 | 1 |
SA205035 | M3_VP_ARMII_041 | Delivery maternal plasma | 1 | 1 |
SA205036 | M3_VP_ARMII_055 | Delivery maternal plasma | 1 | 2 |
SA205037 | M3_VP_ARMII_056 | Delivery maternal plasma | 1 | 2 |
SA205038 | M3_VP_ARMII_052 | Delivery maternal plasma | 1 | 2 |
SA205039 | M3_VP_ARMII_037 | Delivery maternal plasma | 1 | 2 |
SA205040 | M3_VP_ARMII_017 | Delivery maternal plasma | 1 | 2 |
SA205041 | M3_VP_ARMII_035 | Delivery maternal plasma | 1 | 2 |
SA205042 | M3_VP_ARMII_065 | Delivery maternal plasma | 1 | 2 |
SA205043 | M3_VP_ARMII_023 | Delivery maternal plasma | 1 | 2 |
SA205044 | M3_VP_ARMII_030 | Delivery maternal plasma | 1 | 3 |
SA205045 | M3_VP_ARMII_039 | Delivery maternal plasma | 1 | 3 |
SA205046 | M3_VP_ARMII_021 | Delivery maternal plasma | 1 | 3 |
SA205047 | M3_VP_ARMII_019 | Delivery maternal plasma | 1 | 3 |
SA205048 | M3_VP_ARMII_016 | Delivery maternal plasma | 1 | 3 |
SA205049 | M3_VP_ARMII_049 | Delivery maternal plasma | 1 | 3 |
SA205050 | M3_VP_ARMII_018 | Delivery maternal plasma | 1 | 3 |
SA205051 | M3_VP_ARMII_068 | Delivery maternal plasma | 1 | 3 |
SA205052 | M3_VP_ARMII_267 | Delivery maternal plasma | 2 | 1 |
SA205053 | M3_VP_ARMII_087 | Delivery maternal plasma | 2 | 1 |
SA205054 | M3_VP_ARMII_069 | Delivery maternal plasma | 2 | 1 |
SA205055 | M3_VP_ARMII_075 | Delivery maternal plasma | 2 | 1 |
SA205056 | M3_VP_ARMII_102 | Delivery maternal plasma | 2 | 1 |
SA205057 | M3_VP_ARMII_100 | Delivery maternal plasma | 2 | 1 |
SA205058 | M3_VP_ARMII_089 | Delivery maternal plasma | 2 | 1 |
SA205059 | M3_VP_ARMII_107 | Delivery maternal plasma | 2 | 2 |
SA205060 | M3_VP_ARMII_079 | Delivery maternal plasma | 2 | 2 |
SA205061 | M3_VP_ARMII_078 | Delivery maternal plasma | 2 | 2 |
SA205062 | M3_VP_ARMII_278 | Delivery maternal plasma | 2 | 2 |
SA205063 | M3_VP_ARMII_085 | Delivery maternal plasma | 2 | 2 |
SA205064 | M3_VP_ARMII_254 | Delivery maternal plasma | 2 | 2 |
SA205065 | M3_VP_ARMII_140 | Delivery maternal plasma | 2 | 2 |
SA205066 | M3_VP_ARMII_265 | Delivery maternal plasma | 2 | 2 |
SA205067 | M3_VP_ARMII_080 | Delivery maternal plasma | 2 | 3 |
SA205068 | M3_VP_ARMII_203 | Delivery maternal plasma | 2 | 3 |
SA205069 | M3_VP_ARMII_243 | Delivery maternal plasma | 2 | 3 |
SA205070 | M3_VP_ARMII_105 | Delivery maternal plasma | 2 | 3 |
SA205071 | M3_VP_ARMII_271 | Delivery maternal plasma | 2 | 3 |
SA205072 | M3_VP_ARMII_086 | Delivery maternal plasma | 2 | 3 |
SA205073 | M3_VP_ARMII_081 | Delivery maternal plasma | 2 | 3 |
SA205074 | M3_VP_ARMII_274 | Delivery maternal plasma | 2 | 3 |
SA205025 | M3_VP_ARMII_072 | Delivery maternal plasma | #N/A | 1 |
SA205026 | M3_VP_ARMII_061 | Delivery maternal plasma | #N/A | 2 |
SA205081 | M1_VP_ARMII_051 | First trimester maternal plasma | 1 | 1 |
SA205082 | M1_VP_ARMII_031 | First trimester maternal plasma | 1 | 1 |
SA205083 | M1_VP_ARMII_033 | First trimester maternal plasma | 1 | 1 |
SA205084 | M1_VP_ARMII_041 | First trimester maternal plasma | 1 | 1 |
SA205085 | M1_VP_ARMII_020 | First trimester maternal plasma | 1 | 1 |
SA205086 | M1_VP_ARMII_064 | First trimester maternal plasma | 1 | 1 |
SA205087 | M1_VP_ARMII_063 | First trimester maternal plasma | 1 | 1 |
SA205088 | M1_VP_ARMII_015 | First trimester maternal plasma | 1 | 1 |
SA205089 | M1_VP_ARMII_054 | First trimester maternal plasma | 1 | 1 |
SA205090 | M1_VP_ARMII_023 | First trimester maternal plasma | 1 | 2 |
SA205091 | M1_VP_ARMII_061 | First trimester maternal plasma | 1 | 2 |
SA205092 | M1_VP_ARMII_056 | First trimester maternal plasma | 1 | 2 |
SA205093 | M1_VP_ARMII_065 | First trimester maternal plasma | 1 | 2 |
SA205094 | M1_VP_ARMII_037 | First trimester maternal plasma | 1 | 2 |
SA205095 | M1_VP_ARMII_055 | First trimester maternal plasma | 1 | 2 |
SA205096 | M1_VP_ARMII_052 | First trimester maternal plasma | 1 | 2 |
SA205097 | M1_VP_ARMII_068 | First trimester maternal plasma | 1 | 3 |
SA205098 | M1_VP_ARMII_039 | First trimester maternal plasma | 1 | 3 |
SA205099 | M1_VP_ARMII_049 | First trimester maternal plasma | 1 | 3 |
SA205100 | M1_VP_ARMII_019 | First trimester maternal plasma | 1 | 3 |
SA205101 | M1_VP_ARMII_030 | First trimester maternal plasma | 1 | 3 |
SA205102 | M1_VP_ARMII_100 | First trimester maternal plasma | 2 | 1 |
SA205103 | M1_VP_ARMII_102 | First trimester maternal plasma | 2 | 1 |
SA205104 | M1_VP_ARMII_069 | First trimester maternal plasma | 2 | 1 |
SA205105 | M1_VP_ARMII_089 | First trimester maternal plasma | 2 | 1 |
SA205106 | M1_VP_ARMII_087 | First trimester maternal plasma | 2 | 1 |
SA205107 | M1_VP_ARMII_075 | First trimester maternal plasma | 2 | 1 |
SA205108 | M1_VP_ARMII_267 | First trimester maternal plasma | 2 | 1 |
SA205109 | M1_VP_ARMII_085 | First trimester maternal plasma | 2 | 2 |
SA205110 | M1_VP_ARMII_107 | First trimester maternal plasma | 2 | 2 |
SA205111 | M1_VP_ARMII_140 | First trimester maternal plasma | 2 | 2 |
SA205112 | M1_VP_ARMII_278 | First trimester maternal plasma | 2 | 2 |
SA205113 | M1_VP_ARMII_265 | First trimester maternal plasma | 2 | 2 |
SA205114 | M1_VP_ARMII_254 | First trimester maternal plasma | 2 | 2 |
SA205115 | M1_VP_ARMII_079 | First trimester maternal plasma | 2 | 2 |
SA205116 | M1_VP_ARMII_078 | First trimester maternal plasma | 2 | 2 |
SA205117 | M1_VP_ARMII_081 | First trimester maternal plasma | 2 | 3 |
SA205118 | M1_VP_ARMII_080 | First trimester maternal plasma | 2 | 3 |
SA205119 | M1_VP_ARMII_105 | First trimester maternal plasma | 2 | 3 |
SA205120 | M1_VP_ARMII_274 | First trimester maternal plasma | 2 | 3 |
SA205121 | M1_VP_ARMII_243 | First trimester maternal plasma | 2 | 3 |
SA205122 | M1_VP_ARMII_203 | First trimester maternal plasma | 2 | 3 |
SA205123 | M1_VP_ARMII_086 | First trimester maternal plasma | 2 | 3 |
SA205124 | M1_VP_ARMII_271 | First trimester maternal plasma | 2 | 3 |
SA205075 | M1_VP_ARMII_072 | First trimester maternal plasma | #N/A | 1 |
SA205076 | M1_VP_ARMII_035 | First trimester maternal plasma | #N/A | 2 |
SA205077 | M1_VP_ARMII_017 | First trimester maternal plasma | #N/A | 2 |
SA205078 | M1_VP_ARMII_021 | First trimester maternal plasma | #N/A | 3 |
SA205079 | M1_VP_ARMII_018 | First trimester maternal plasma | #N/A | 3 |
Collection:
Collection ID: | CO002213 |
Collection Summary: | Standard blood plasma collection protocol |
Sample Type: | Blood (plasma) |
Treatment:
Treatment ID: | TR002232 |
Treatment Summary: | This is observational study |
Sample Preparation:
Sampleprep ID: | SP002226 |
Sampleprep Summary: | Standard MRC2 untargeted metabolomics and lipidomics sample preparation protocols |
Sampleprep Protocol Filename: | araskind_20210615_101412_PR_SP_A004_Shotgun_Lipidomics.PDF araskind_20210611_105341_PR_SP_Untargeted_metabolomics_analysis.DOC |
Combined analysis:
Analysis ID | AN003493 | AN003494 | AN003495 | AN003496 |
---|---|---|---|---|
Analysis type | MS | MS | MS | MS |
Chromatography type | Reversed phase | Reversed phase | Reversed phase | Reversed phase |
Chromatography system | Agilent 1290 Infinity II | Agilent 1290 Infinity II | Shimadzu Prominence UFLC | Shimadzu Prominence UFLC |
Column | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
MS Type | ESI | ESI | ESI | ESI |
MS instrument type | QTOF | QTOF | Triple TOF | Triple TOF |
MS instrument name | Agilent 6545 QTOF | Agilent 6545 QTOF | ABI Sciex 5600+ TripleTOF | ABI Sciex 5600+ TripleTOF |
Ion Mode | NEGATIVE | POSITIVE | NEGATIVE | POSITIVE |
Units | Peak area | Peak area | Peak area, normalized | Peak area, normalized |
Chromatography:
Chromatography ID: | CH002579 |
Chromatography Summary: | Untargeted reverse phase negative mode |
Instrument Name: | Agilent 1290 Infinity II |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002580 |
Chromatography Summary: | Untargeted reverse phase positive mode |
Instrument Name: | Agilent 1290 Infinity II |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002581 |
Chromatography Summary: | Lipidomics reverse phase negative mode |
Instrument Name: | Shimadzu Prominence UFLC |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
Chromatography ID: | CH002582 |
Chromatography Summary: | Lipidomics reverse phase positive mode |
Instrument Name: | Shimadzu Prominence UFLC |
Column Name: | Waters Acquity BEH HSS T3 (100 x 2.1mm,1.8um) |
Chromatography Type: | Reversed phase |
MS:
MS ID: | MS003253 |
Analysis ID: | AN003493 |
Instrument Name: | Agilent 6545 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Acquisition method RP Neg Untargeted_2016_460ulmin_Agilent.m, Processing in Agilent Qual/MPP followed by in-house scripts |
Ion Mode: | NEGATIVE |
MS ID: | MS003254 |
Analysis ID: | AN003494 |
Instrument Name: | Agilent 6545 QTOF |
Instrument Type: | QTOF |
MS Type: | ESI |
MS Comments: | Acquisition method: RP Pos Untargeted_2016_Agilent_460ulmin_2mm.m, Processing in Agilent Qual/MPP followed by in-house scripts |
Ion Mode: | POSITIVE |
MS ID: | MS003255 |
Analysis ID: | AN003495 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
MS Comments: | Acquisition method LIP_15min_MSMS_Jenny_New_20min_Negative.dam, Processing in Sciex proprietary software followed by in-house scripts |
Ion Mode: | NEGATIVE |
MS ID: | MS003256 |
Analysis ID: | AN003496 |
Instrument Name: | ABI Sciex 5600+ TripleTOF |
Instrument Type: | Triple TOF |
MS Type: | ESI |
MS Comments: | Acquisition method LIP_15min_MSMS_Jenny_new_20min_Positive.dam, Processing in Sciex proprietary software followed by in-house scripts |
Ion Mode: | POSITIVE |